[CML] Novartis's Vasella Struggles to Raise Profit on Lack of Drugs

[Rob]

Novartis AG, Switzerland's biggest drugmaker, may say second-quarter earnings rose 4 percent as Chief Executive Daniel Vasella spent money to develop new treatments and promote aging bestsellers such as the Diovan heart medicine.... Vasella, 52, received total compensation of 20.8 million Swiss francs ($16 million) in 2004, including salary and stock awards and options, Novartis said in its annual report. Vasella declined, through spokesman John Gilardi, to be interviewed for this article.     http://cmlsupport.blogspot.com/2005/07/novartiss-vasella-struggles-to-raise.html New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: cml@yahoogroups.com Subscribe:  [EMAIL PROTECTED] Unsubscribe:  [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED]  CML Group Web Site http://groups.yahoo.com/group/CML YAHOO! GROUPS LINKS  Visit your group "CML" on the web.    To unsubscribe from this group, send an email to:  [EMAIL PROTECTED]    Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.